Vascular Inflammation Stratified by Body Size Phenotype
NCT01979068 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2013-11-08
Summary
* Vascular Inflammation is a key factor in both the pathogenesis and outcome of atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying vascular inflammation within atherosclerotic plaque
* Recently, unique subsets of obese individuals, such as metabolically obese but normal weight (MONW) and metabolically healthy obese (MHO), have been getting an attention
* Therefore, the purpose of this study is to examine the relationship of vascular inflammation,measured by FDG-PET, with various body sized phenotypes
Conditions
- Atherosclerosis
- Obesity
- Metabolic Syndrome
Sponsors & Collaborators
-
Korea University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2011-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Association Between Obesity-Related Indicators and Adverse Outcomes in Ischemic Stroke Patients
NCT06165107 ·Status: COMPLETED
-
BeijngFH Health Cohort Study
NCT05546086 ·Status: RECRUITING
-
Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
NCT00510588 ·Status: COMPLETED ·Phase: NA
-
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19
NCT05771857 ·Status: COMPLETED
-
Evaluation of Systemic Microvascular Endothelial Function in Metabolically Healthy Obesity
NCT04233528 ·Status: COMPLETED ·Phase: NA
-
Body Composition and Fatty Liver Disease
NCT05695118 ·Status: UNKNOWN ·Phase: NA
-
Characterization of Bile Acid Pathway in Obesity
NCT03341052 ·Status: COMPLETED ·Phase: NA
-
Abdominal Fat and Imaging Measurements of Heart Disease
NCT01447745 ·Status: COMPLETED
-
Association of Circulating Chemerin Levels and Arterial Stiffness
NCT01293929 ·Status: UNKNOWN
-
The Effects of VEGF-B Signaling Pathway in Obesity and Metabolic Disease
NCT03164005 ·Status: COMPLETED
-
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167 ·Status: ENROLLING_BY_INVITATION
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
CT Evaluation of Cardiovascular Risk Markers in Obese Patients
NCT03111693 ·Status: UNKNOWN
-
Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines
NCT02799719 ·Status: COMPLETED
-
Body Weight and Vascular Function
NCT01675401 ·Status: COMPLETED ·Phase: NA
-
Systemic and White Adipose Tissue Inflammatory Profile in Lean Versus Obese Individuals
NCT04078776 ·Status: COMPLETED
-
Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease
NCT00510705 ·Status: TERMINATED ·Phase: NA
-
Association Between BMI and COVID-19
NCT04391738 ·Status: COMPLETED
-
A Prospective Cohort Study of Aged People for Chronic Diseases
NCT02640872 ·Status: COMPLETED
-
Impact of Adipose Tissue in COVID-19
NCT04639440 ·Status: UNKNOWN
-
Clinical Classification and Imaging Markers in Patients of Obesity
NCT06649071 ·Status: ENROLLING_BY_INVITATION
-
Inflammation Regulation in Obese Patients
NCT01561664 ·Status: COMPLETED ·Phase: NA
-
A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
NCT05873660 ·Status: COMPLETED
-
Molecular, Cellular, and Genetic Characterization of Human Adipose Tissue and Its Role in Metabolism
NCT02692885 ·Status: RECRUITING
-
Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis
NCT01282892 ·Status: UNKNOWN